Covered recipient · General Payments record
AMY L HENNESSY
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,783.25
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $444.84 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $262.98 | 9 |
| Sight Sciences, Inc. | $62.01 | 3 |
| GLAUKOS CORPORATION | $34.51 | 1 |
| Astellas Pharma US Inc | $33.44 | 1 |
| Oyster Point Pharma, Inc. | $20.83 | 1 |
| Thea Pharma Inc. | $16.01 | 1 |
| ABBVIE INC. | $15.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.06 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103905356 | CMS |
| Alcon Vision LLC | $20.96 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607274 | CMS |
| Alcon Vision LLC | $9.11 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607266 | CMS |
| Alcon Vision LLC | $19.84 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607272 | CMS |
| Alcon Vision LLC | $115.31 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607280 | CMS |
| Alcon Vision LLC | $13.63 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607268 | CMS |
| Alcon Vision LLC | $30.64 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607276 | CMS |
| Alcon Vision LLC | $33.55 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607278 | CMS |
| Alcon Vision LLC | $4.64 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607264 | CMS |
| Alcon Vision LLC | $15.30 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110607270 | CMS |
| Astellas Pharma US Inc | $33.44 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139371513 | CMS |
| Glaukos Corporation | $34.51 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151978666 | CMS |
| Oyster Point Pharma, Inc. | $20.83 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147422383 | CMS |
| Sight Sciences, Inc. | $21.58 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151922061 | CMS |
| Sight Sciences, Inc. | $21.45 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151922054 | CMS |
| Sight Sciences, Inc. | $18.98 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151922050 | CMS |
| Thea Pharma Inc. | $16.01 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074541475 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.